Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
40
NCT06440239
A Study to Evaluate the Safety, Tolerability and Efficacy in Patients With Burn(s)
Phase: Phase 1/2
Role: Lead Sponsor
Start: Jan 1, 2025
Completion: Feb 28, 2025